Potential role of ginseng in the treatment of colorectal cancer
- PMID: 19051332
- PMCID: PMC2676850
- DOI: 10.1142/S0192415X08006545
Potential role of ginseng in the treatment of colorectal cancer
Abstract
Colorectal cancer remains one of the most prevalent cancer and a leading cause of cancer related death in the US. Many currently used chemotherapeutic agents are derived from botanicals. Identifying herbal sources, including those from ginseng family, to develop better anti-cancer therapies remains an essential step in advancing the treatment of the cancer. In this article, potential roles of ginseng herbs, especially American ginseng and notoginseng, in colorectal cancer therapeutics are presented. The major pharmacologically active constituents of ginsengs are ginsenosides, which can be mainly classified as protopanaxadiol and protopanaxatriol groups. Structure-activity relationship between their chemical structures and pharmacological activities are discussed. In addition, various steaming temperature and time treatment of the ginseng herbs can change ginsenoside profiles, and enhance their anti-cancer activities. This heat treatment process may increase the role of ginseng in treating colorectal cancer.
Figures
References
-
- Akerele O. Nature’s medicinal bounty: don’t throw it away. World Health Forum. 1993;14:390–395. - PubMed
-
- Assinewe VA, Baum BR, Gagnon and D, Arnason JT. Phytochemistry of wild populations of Panax quinquefolius L. (North American ginseng) J Agric Food Chem. 2003;51:4549–4553. - PubMed
-
- Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol. 1999;58:1685–1693. - PubMed
-
- Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data. 2004;343:1–19. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical